CA2246487A1 - Dosage de l'adn pour prevoir le diabete auto-immun - Google Patents
Dosage de l'adn pour prevoir le diabete auto-immun Download PDFInfo
- Publication number
- CA2246487A1 CA2246487A1 CA 2246487 CA2246487A CA2246487A1 CA 2246487 A1 CA2246487 A1 CA 2246487A1 CA 2246487 CA2246487 CA 2246487 CA 2246487 A CA2246487 A CA 2246487A CA 2246487 A1 CA2246487 A1 CA 2246487A1
- Authority
- CA
- Canada
- Prior art keywords
- alleles
- class iii
- ins
- allele
- class
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2246487 CA2246487A1 (fr) | 1998-09-03 | 1998-09-03 | Dosage de l'adn pour prevoir le diabete auto-immun |
US09/909,962 US6534272B2 (en) | 1998-09-03 | 2001-07-23 | DNA assay for the prediction of autoimmune diabetes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA 2246487 CA2246487A1 (fr) | 1998-09-03 | 1998-09-03 | Dosage de l'adn pour prevoir le diabete auto-immun |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2246487A1 true CA2246487A1 (fr) | 2000-03-03 |
Family
ID=29409840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2246487 Abandoned CA2246487A1 (fr) | 1998-09-03 | 1998-09-03 | Dosage de l'adn pour prevoir le diabete auto-immun |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2246487A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003012139A2 (fr) * | 2001-07-31 | 2003-02-13 | Pierre Bougneres | Methodes d'evaluation du risque d'obesite reposant sur des variations alleliques dans la region flanquante 5' du gene de l'insuline |
-
1998
- 1998-09-03 CA CA 2246487 patent/CA2246487A1/fr not_active Abandoned
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003012139A2 (fr) * | 2001-07-31 | 2003-02-13 | Pierre Bougneres | Methodes d'evaluation du risque d'obesite reposant sur des variations alleliques dans la region flanquante 5' du gene de l'insuline |
WO2003012139A3 (fr) * | 2001-07-31 | 2003-09-18 | Pierre Bougneres | Methodes d'evaluation du risque d'obesite reposant sur des variations alleliques dans la region flanquante 5' du gene de l'insuline |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1996728B1 (fr) | Détection d'anomalies chromosomiques à l'aide de polymorphismes mononucléotidiques tandem | |
EP2118298B1 (fr) | Tests a base d'acide nucléique destinés au typage rhd | |
US10081841B2 (en) | Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms | |
US20090186340A1 (en) | Gene Analysis | |
EP2821503B1 (fr) | Procédé de détection de l'allèle hla-a*31:01 | |
JP4073471B2 (ja) | 塩基変異分析用プライマー | |
Hessner et al. | Genotyping of KEL1 and KEL2 of the human Kell blood group system by the polymerase chain reaction with sequence‐specific primers | |
Navon et al. | Prenatal diagnosis of Charcot‐Marie‐Tooth disease type 1A (CMT1A) using molecular genetic techniques | |
US6534272B2 (en) | DNA assay for the prediction of autoimmune diabetes | |
US6303294B1 (en) | Methods of detecting genetic deletions and mutations associated with Digeorge syndrome, Velocardiofacial syndrome, CHARGE association, conotruncal cardiac defect, and cleft palate and probes useful therefore | |
Camaschella et al. | Allelic association of microsatellites of 6p in Italian hemochromatosis patients | |
Hessner et al. | Prenatal genotyping of Jka and Jkb of the human Kidd blood group system by allele‐specific polymerase chain reaction | |
EP0787806B1 (fr) | Polymorphismes de la séquence de la glycosyltransferase ABO | |
CA2246487A1 (fr) | Dosage de l'adn pour prevoir le diabete auto-immun | |
WO2013052862A1 (fr) | Marqueur génétique pour la prédiction du pronostic chez des patients infectés avec le virus de l'hépatite c | |
US20040091897A1 (en) | Disease associated polymorphism in the ctla-4 locus | |
KR102063486B1 (ko) | Rnf213 단일염기다형성과 한국인 모야모야병 발병 위험도의 연관성 | |
Fodor et al. | Molecular exclusion of haemoglobin SD disease by prenatal diagnosis | |
CN112940099B (zh) | RhD-T163P突变体及其检测 | |
Horiuchi et al. | Polymerase chain reaction-based analysis using deaminated DNA of dodecamer expansions in CSTB, associated with Unverricht-Lundborg myoclonus epilepsy | |
WO2002066639A1 (fr) | Gene sensible a l'anevrisme cerebral | |
Matsuo et al. | Allele‐specific restriction analysis of human platelet antigen system 4 | |
Ahmed | An approach for the prevention of thalassaemia in Pakistan | |
EP2380992A1 (fr) | Procédé de prédiction d'une réponse anticorps dans la thérapie à interférons chez les patients souffrant de sclérose en plaques | |
US20190100799A1 (en) | Compositions and methods of detecting myelitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |